Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
117,557,908
-
Total 13F shares
-
77,884,791
-
Share change
-
+7,712,824
-
Total reported value
-
$15,246,137,868
-
Put/Call ratio
-
18%
-
Price per share
-
$195.82
-
Number of holders
-
332
-
Value change
-
+$1,517,689,271
-
Number of buys
-
213
-
Number of sells
-
112
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q2 2021
As of 30 Jun 2021,
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by
332 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,884,791 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, BAILLIE GIFFORD & CO, MORGAN STANLEY, ARK Investment Management LLC, 12 West Capital Management LP, Meritech Capital Associates V L.L.C., Foresite Capital Management II, LLC, and Sumitomo Mitsui Trust Holdings, Inc..
This page lists
332
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.